Drug Trial Radar · NCT00000736
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
Last checked: Nov 20, 2026Latest source record: Nov 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,200
Actual
Start
Not stated
Primary completion
Not stated
Study completion Feb 1995
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine if treatment with zidovudine (AZT) will delay or prevent the onset of AIDS or AIDS related complex (ARC) in individuals infected with HIV but who do not have symptoms of AIDS or ARC. Also, to compare the dose of AZT found to be useful in AIDS and severe ARC with a lower dose to see if side effects can be reduced. Results from several studies show that a high percentage of people infected with HIV will eventually develop AIDS or ARC unless an effective treatment is found. Because AZT is known to prolong survival in patients with AIDS or severe ARC and has acceptable toxicity in advanced disease, it is reasonable to try it in less advanced cases.
Conditions
- HIV Infections
Interventions
ZidovudineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
43 sites in 1 country. Site status is shown where the registry gives one.
Los Angeles County - USC Med Ctr
Los Angeles, California
UCLA CARE Ctr
Los Angeles, California
Summitt Med Ctr / San Francisco Gen Hosp
Oakland, California
Palo Alto Veterans Adm Med Ctr / Stanford Univ
Palo Alto, California
Univ of California / San Diego Treatment Ctr
San Diego, California
San Francisco AIDS Clinic / San Francisco Gen Hosp
San Francisco, California
Stanford at Kaiser / Kaiser Permanente Med Ctr
San Francisco, California
Children's Hosp of San Francisco
San Francisco, California
San Francisco AIDS Clinic
San Francisco, California
Stanford Univ School of Medicine
Stanford, California
Harbor UCLA Med Ctr
Torrance, California
George Washington Univ Med Ctr
Washington D.C., District of Columbia
Northwestern Univ Med School
Chicago, Illinois
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois
Johns Hopkins Hosp
Baltimore, Maryland
Harvard (Massachusetts Gen Hosp)
Boston, Massachusetts
Beth Israel Deaconess - West Campus
Boston, Massachusetts
Beth Israel Deaconess Med Ctr
Boston, Massachusetts
Univ of Minnesota
Minneapolis, Minnesota
St Louis Regional Hosp / St Louis Regional Med Ctr
St Louis, Missouri
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York
City Hosp Ctr at Elmhurst / Mount Sinai Hosp
Elmhurst, New York
Beth Israel Med Ctr / Peter Krueger Clinic
New York, New York
Bellevue Hosp / New York Univ Med Ctr
New York, New York
Cornell Univ Med Ctr
New York, New York
Mem Sloan - Kettering Cancer Ctr
New York, New York
Saint Luke's - Roosevelt Hosp Ctr
New York, New York
Mount Sinai Med Ctr
New York, New York
Univ of Rochester Medical Center
Rochester, New York
SUNY - Stony Brook
Stony Brook, New York
SUNY / State Univ of New York
Syracuse, New York
Bronx Municipal Hosp Ctr/Jacobi Med Ctr
The Bronx, New York
Jack Weiler Hosp / Bronx Municipal Hosp
The Bronx, New York
Montefiore Med Ctr / Bronx Municipal Hosp
The Bronx, New York
Bronx Veterans Administration / Mount Sinai Hosp
The Bronx, New York
Duke Univ Med Ctr
Durham, North Carolina
Holmes Hosp / Univ of Cincinnati Med Ctr
Cincinnati, Ohio
Univ Hosp of Cleveland / Case Western Reserve Univ
Cleveland, Ohio
Columbus Children's Hosp
Columbus, Ohio
Ohio State Univ Hosp Clinic
Columbus, Ohio
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.